Endogenous danger signals trigger hepatic ischemia/reperfusion injury through toll-like receptor 4/nuclear factor-kappa B pathway
- PMID: 17439747
Endogenous danger signals trigger hepatic ischemia/reperfusion injury through toll-like receptor 4/nuclear factor-kappa B pathway
Abstract
Background: Restoration of blood flow to the ischemic liver lobes may paradoxically exacerbate tissue injury, which is called hepatic ischemia/reperfusion injury (IRI). Toll-like receptor 4 (TLR4), expressed on several liver cell types, and the nuclear factor-kappa B (NF-kappaB) signaling pathway are crucial to mediating hepatic inflammatory response. Because IRI is essentially a kind of profound acute inflammatory reaction evoked by many kinds of danger signals, we investigated TLR4/NF-kappaB signaling pathway activation in a murine model of partial hepatic IRI.
Methods: Wild-type mice (WT, C3H/HeN) or TLR4 mutant mice (C3H/HeJ) were subjected to 45 minutes of partial hepatic ischemia followed by 1 hour, 3 hours of reperfusion. Sham group accepted the same procedure without the obstruction of blood supply. At the end of reperfusion, the compromise of liver function and the histological change of liver sections were measured as the severity of liver injury. The level of endotoxin in the portal vein was measured by limulus assay. NF-kappaB activation was determined by electrophoretic mobility shift assay (EMSA). The levels of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta) in systemic blood after hepatic IRI were assessed by enzyme-linked immunosorbent assay (ELISA).
Results: The compromise of liver function and the morphological injuries in mutant mice were relieved more markedly than those in WT mice after partial hepatic IRI. NF-kappaB activation in WT mice was stronger than that in TLR4 mutant mice, and both were stronger than those in the sham operated mice (P < 0.01). Endotoxin in each group was undetectable. The levels of TNF-alpha and IL-1beta in systemic blood were elevated in both strains, but lower in the sham operated group. These mediators were significantly decreased in TLR4 mutant mice compared with those in WT mice (P < 0.01).
Conclusions: The TLR4/NF-kappaB signaling pathway may mediate hepatic IRI triggered by endogenous danger signals. Inhibition of the TLR4/NF-kappaB pathway may be a potential therapeutic target for attenuating ischemia/reperfusion-induced tissue damage in some clinical settings.
Similar articles
-
Toll-like receptor 4 involvement in hepatic ischemia/reperfusion injury in mice.Hepatobiliary Pancreat Dis Int. 2004 May;3(2):250-3. Hepatobiliary Pancreat Dis Int. 2004. PMID: 15138120
-
TLR ligand decreases mesenteric ischemia and reperfusion injury-induced gut damage through TNF-alpha signaling.Shock. 2008 Nov;30(5):563-70. doi: 10.1097/SHK.0b013e31816a3458. Shock. 2008. PMID: 18317407
-
Toll-like receptor-4 signaling mediates hepatic injury and systemic inflammation in hemorrhagic shock.J Am Coll Surg. 2006 Mar;202(3):407-17. doi: 10.1016/j.jamcollsurg.2005.11.021. Epub 2006 Jan 18. J Am Coll Surg. 2006. PMID: 16500244
-
Intracellular survival pathways in the liver.Liver Int. 2006 Dec;26(10):1163-74. doi: 10.1111/j.1478-3231.2006.01366.x. Liver Int. 2006. PMID: 17105581 Review.
-
Toll-like receptors: a novel target for therapeutic intervention in intestinal and hepatic ischemia-reperfusion injury?Expert Opin Ther Targets. 2010 Aug;14(8):839-53. doi: 10.1517/14728222.2010.500286. Expert Opin Ther Targets. 2010. PMID: 20568914 Review.
Cited by
-
Pretreatment with lipopolysaccharide attenuates diethylnitrosamine-caused liver injury in mice via TLR4-dependent induction of Kupffer cell M2 polarization.Immunol Res. 2015 Jun;62(2):137-45. doi: 10.1007/s12026-015-8644-2. Immunol Res. 2015. PMID: 25846584
-
Toll-like receptor-4 coordinates the innate immune response of the kidney to renal ischemia/reperfusion injury.PLoS One. 2008;3(10):e3596. doi: 10.1371/journal.pone.0003596. Epub 2008 Oct 31. PLoS One. 2008. PMID: 18974879 Free PMC article.
-
N-acetyl-L-tryptophan attenuates hepatic ischemia-reperfusion injury via regulating TLR4/NLRP3 signaling pathway in rats.PeerJ. 2021 Aug 10;9:e11909. doi: 10.7717/peerj.11909. eCollection 2021. PeerJ. 2021. PMID: 34434653 Free PMC article.
-
Protein kinase C-β inhibitor treatment attenuates hepatic ischemia and reperfusion injury in diabetic rats.Exp Ther Med. 2016 Feb;11(2):565-570. doi: 10.3892/etm.2015.2927. Epub 2015 Dec 9. Exp Ther Med. 2016. PMID: 26893648 Free PMC article.
-
The danger model approach to the pathogenesis of the rheumatic diseases.J Immunol Res. 2015;2015:506089. doi: 10.1155/2015/506089. Epub 2015 Apr 20. J Immunol Res. 2015. PMID: 25973436 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources